Cremophor-free intravenous microemulsions for paclitaxel. II. Stability, in vitro release and pharmacokinetics

International Journal of Pharmaceutics

Volumn 349, Issue 1-2, 2008, Pages 117-123

  Nornoo, Adwoa O ^a   Chow, Diana S L ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

In vitro release; Intravenous; Microemulsion; Paclitaxel; Pharmacokinetics; Stability

Indexed keywords

ALCOHOL; BUTANOL; CREMOPHOR; MONOACYLGLYCEROL; MYVACET; OCTANOIN; PACLITAXEL; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSIS; DRUG ACTIVATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; FEMALE; IN VITRO STUDY; MALE; MICROEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; DRUG STABILITY; EMULSIONS; EXCIPIENTS; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; NANOPARTICLES; PACLITAXEL; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 37349124878     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.07.043     Document Type: Article

References (18)

1. Bagwe R.P., Kanicky J.R., Palla B.J., Patanjali P.K., and Shah D.O. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 77-140
2. Beijnen J.H., Huizing M.T., Ten bokkel huinink W.W., Veenhof C.H., Vermorken J.B., Giaccone G., and Pinedo H.M. Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol.). Semin. Oncol. 21 (1994) 53-62
3. Bielawski J. Two types of hemolytic activity of detergents. Biochim. Biophys. 1035 (1990) 214-217
4. Gaver R.C., Deeb G., and Wiley T. The disposition of paclitaxel (Taxol) in the rat. Proc. Am. Assoc. Cancer Res. (1993) pp. 340
5. Gursoy N., Garrigue J.S., Razafindratsita A., Lambert G., and Benita S. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J. Pharm. Sci. 92 (2003) 2411-2418
6. He L., Wang G.L., and Zhang Q. An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile. Int. J. Pharm. 250 (2003) 45-50
7. Kang B.K., Chon S.K., Kim S.H., Jeong S.Y., Kim M.S., Cho S.H., Lee H.B., and Khang G. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int. J. Pharm. 286 (2004) 147-156
8. Meerum Terwogt J.M., Nuijen B., Ten Bokkel Huinink W.W., and Beijnen J.H. Alternative formulations of paclitaxel. Cancer Treat. Rev. 23 (1997) 87-95
9. Shimomura T., Fujiwara H., Ikawa S., Kigawa K., and Terakawa N. Effects of Taxol on blood cells. Lancet 352 (1998) 541-542
10. ®, 2007. Solution for Injection. Drug Information. [database on the internet] Clinical Pharmacology, Tampa, FL. Gold Standard c 2007. [revised 3/22/2007, cited 04/02/2007].
11. Trissel L.A. Pharmaceutical properties of paclitaxel and their effects on preparation and administration. Pharmacotherapy 17 (1997) 133S-139S
12. Vinod P.S., Konecny J.J., Everett R.L., Mccullough B., Noorizadeh A.C., and Skelley J.P. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res. 6 (1989) 612-618
13. Vyas D.M. Paclitaxel (Taxol) formulation and prodrugs. In: Farina V. (Ed). The Chemistry and Pharmacology of Taxol and its derivatives (1995), British Vancouver, Elsvier Science
14. Wang L.Z., Ho P.C., Lee H.S., Vaddi H.K., Chan Y.W., and Yung C.S. Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay. J. Pharm. Biomed. Anal. 31 (2003) 283-289
15. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and Mcphail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93 (1971) 2325-2327
16. Wigent R.J. Chemical kinetics. In: Gennaro A.R. (Ed). Remingtons' Pharmaceutical Sciences. 21 ed. (2005), Mack Publishing Co., Pennsylvania, PA
17. Yang S., Gursoy R.N., Lambert G., and Benita S. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm. Res. 21 (2004) 261-270
18. Zhang X.N., Tang L.H., Yan X.Y., and Zhang Q. The influence of absorption enhancer and preparation of paclitaxel on its intestinal mucous membrane permeation detected by enhancement by using electron spin resonance technique. Yao Xue Xue Bao 40 (2005) 861-864